Related Experiment Video
Updated: Jul 7, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
Published on: March 17, 2023
Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents
Abstract:
In 1971, thyroid function was evaluated in 15 unselected patients whose only therapy for diffuse toxic goiter was a course of thionamide drug treatment completed 20-27 yr earlier. One patient was frankly hypothyroid by clinical and laboratory criteria. The remaining 14 patients appeared clinically euthyroid and had a normal serum thyroxine (T(4)) concentration and thyroid radioiodine uptake (RAIU). Nevertheless, only 6 of 14 appeared to be entirely normal according to more refined criteria. The serum thyrotropin (TSH) concentration was markedly elevated in one patient and above the normal range (1.6+/-2.0; mean+/-2 SD) in five others. Thyroid stimulation with exogenous TSH revealed subnormal responses of the serum T(4)I, RAIU, or both, in 7 of 11 patients tested. An abnormal iodideperchlorate discharge test was found in 5 of 10 patients and appeared most abnormal in patients with abnormal RAIU responses to TSH. Fluorescent antimicrosomal antibody was found in the serum of 12 of the 15 patients, in contrast to an expected frequency of 7% in normal individuals of the same age. By the time a second major follow-up study was completed in 1978, two additional patients had become frankly hypothyroid. A third subject met accepted criteria for subclinical hypothyroidism. One of these subjects had had a clearly elevated serum TSH concentration in 1972, and the remaining two had exhibited the highest responses of serum TSH (36, 26 muU/ml) to thyrotropin-releasing hormone among 10 patients tested in 1972. One patient developed recurrent thyrotoxicosis in 1978, 25 yr after the onset of his first and only other apparent episode of hyperthyroidism. This patient was the only one who demonstrated a subnormal response to thyrotropin-releasing hormone in 1972. The remaining nine subjects that could be studied in 1978 exhibited varying combinations of abnormalities of thyroid function. It is concluded that progressive failure of thyroid function is a common occurence in long-standing Graves' disease, and it is suggested that this results from concomitant chronic thyroiditis. We postulate that this inherent tendency toward thyroid failure is exaggerated by surgery or radioactive iodine, explaining the progressive increase in, and inordinate frequency of, hypothyroidism after ablative modes of therapy in diffuse toxic goiter.
Insights
Long-term thionamide treatment for Graves
Area of Science:
- Endocrinology
- Thyroidology
Background:
- Graves' disease is a common cause of hyperthyroidism.
- Thionamide drugs are a primary treatment for Graves' disease.
- Long-term effects of thionamide treatment on thyroid function require further investigation.
Purpose of the Study:
- To evaluate long-term thyroid function in patients treated with thionamides for diffuse toxic goiter.
- To identify potential risk factors for developing hypothyroidism after thionamide therapy.
Main Methods:
- Thyroid function tests (serum thyroxine, TSH, RAIU) were performed in 15 patients 20-27 years after thionamide treatment.
- Thyroid stimulation tests with TSH and TRH were conducted.
- Iodideperchlorate discharge tests and antimicrosomal antibody assays were performed.
Main Results:
- One patient was hypothyroid, and 7 of 14 euthyroid patients showed subnormal responses to TSH stimulation.
- Elevated TSH levels were observed in 6 patients.
- Antimicrosomal antibodies were present in 12 of 15 patients.
- By 1978, two additional patients became hypothyroid, and one developed recurrent hyperthyroidism.
Conclusions:
- Progressive thyroid function failure is common in long-standing Graves' disease, likely due to chronic thyroiditis.
- Surgery or radioactive iodine may exacerbate the tendency toward thyroid failure.
- Hypothyroidism is a frequent long-term complication of diffuse toxic goiter treatment.
Related Concept Videos
Hyperthyroidism I: Introduction
Hyperthyroidism II: Pathophysiology
Graves' Disease I: Introduction
Graves Disease II: Pathophysiology
Goiter
Hypothyroidism II: Pathophysiology

